Cover Image

The synergistic effect of PKA activator and HDAC inhibitor to reactivate HIV-1 provirus from latently infected cells

Saved in:

Bibliographic Details
Main Authors:	B.S. Choi (Author), H. Lim (Author), K.C. Kim (Author), Y. Shin (Author), C.H. Yoon (Author), C. Kang (Author)
Format:	Book
Published:	Elsevier, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A quantitative single cell, single molecule RNA-FISH+IF and single cell RNA-seq analysis reveals stochasticity of reactivation of latent provirus
by: G. Kalpana, et al.
Published: (2019)

PP 1.2 - 00011 Structural rearrangements in the nucleus localize latent HIV proviruses to a perinucleolar zone supportive of early transcription reactivation
by: F. Kizito, et al.
Published: (2022)

7 A single-cell method to detect early activation of the latent HIV provirus
by: J.P. Svensson
Published: (2017)

Reactivation of HIV-1 proviruses in immune-compromised mice engrafted with human VOA-negative CD4+ T cells
by: Zhe Yuan, et al.
Published: (2017)

CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5' long terminal repeats to permanently inactivate latent provirus
by: B. Wigdahl, et al.
Published: (2019)

HIV-1 proviruses which are integrated into cancer-related genes are inducible
by: A. Varabyou, et al.
Published: (2017)

Synergistic antitumor activity of artesunate and HDAC inhibitors through elevating heme synthesis via synergistic upregulation of ALAS1 expression
by: Cai-Ping Chen, et al.
Published: (2019)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

Ingenol derivatives are potent reactivators of latent HIV
by: V. Planelles, et al.
Published: (2015)

Reactivation of VOA-inducible and -uninducible HIV-1 proviruses using immune-compromised mice engrafted with human resting CD4+ T cells
by: Z. Yuan, et al.
Published: (2015)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
by: Elizabeth A. Thomas
Published: (2014)

9 LEDGIN-mediated inhibition of the IN-LEDGF/p75 interaction reduces provirus reactivation from latency
by: Zeger Debyser, et al.
Published: (2017)

Characterizing HIV expression of proviruses during ART in tissues and blood
by: W.R. McManus, et al.
Published: (2017)

Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma
by: Nemanja Djokovic, et al.
Published: (2023)

Regulation of HIV-1 provirus and CD4+ T cell biology by transcriptional coregulators
by: B.C. Nikolai, et al.
Published: (2017)

The efficacy of HDAC inhibitors in neoplasm treatment
by: Dominika Psiuk, et al.
Published: (2020)

Nanomaterials as potential transporters of HDAC inhibitors
by: Cristabelle De Souza, et al.
Published: (2020)

Whole genome sequencing of single HIV provirus and its proviral integration site for the study of HIV latency
by: C. Sun, et al.
Published: (2017)

Cellular modulation and HIV reactivation in response to serial treatment of latently HIV infected CD4 T cells with histone deacetylase inhibitors (HDACi)
by: J. Maxwell, et al.
Published: (2019)

Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML
by: Qing Ling, et al.
Published: (2023)

Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages.
by: Roberto Gimmelli, et al.
Published: (2024)

Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
by: María Galán, et al.
Published: (2016)

Phosphorus containing analogues of SAHA as inhibitors of HDACs
by: Michael D. Pun, et al.
Published: (2022)

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022)

Role of mitochondrial antiviral signaling protein in reactivation of latent HIV-1 in CD4+ T cells
by: C.L. Novis, et al.
Published: (2017)

Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
by: Beatriz Silva Urias, et al.
Published: (2022)

Evaluation of Novel 3-Hydroxyflavone Analogues as HDAC Inhibitors against Colorectal Cancer
by: Subhankar Biswas, et al.
Published: (2018)

Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors
by: Omnia R. Elbatrawy, et al.
Published: (2023)

HBV-related inflammation is linked to the level of genetically intact HIV proviruses
by: X. Wang, et al.
Published: (2019)

BCL-2 inhibitor sensitizes the latent HIV reservoir to elimination by CTLs
by: S.-H. Huang, et al.
Published: (2017)

Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
by: Wang Y, et al.
Published: (2017)

PP 5.6 - 00183 Combination of traditional medicine product (SDK-2) with TNF-α synergistically reactivate latent HIV-1 subtype C in vitro
by: K. Mngomezulu, et al.
Published: (2022)

Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer
by: Fabiana Sélos Guerra, et al.
Published: (2021)

The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs.
by: Hugo Rolando Vaca, et al.
Published: (2021)

HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
by: Xing Lyu, et al.
Published: (2019)

Opportunities and Difficulties in the Repurposing of HDAC Inhibitors as Antiparasitic Agents
by: Tapas Kumar Mohapatra, et al.
Published: (2024)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
by: Cristina Maccallini, et al.
Published: (2022)

Effects of heme degradation products on reactivation of latent HIV-1
by: Z. Melkova, et al.
Published: (2015)

Mixed effects of HDACi on host gene expression and their implications for HIV reactivation from latency
by: N. Beliakova-Bethell, et al.
Published: (2015)

Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors
by: Rupesh Agarwal, et al.
Published: (2024)